NCT06566196

Brief Summary

The purpose of this study is to compare the difference in the ability to detect hemodynamic abnormalities between invasive hemodynamic assessments performed at rest versus exercise, to assess the correlation between invasive and noninvasive (Doppler-derived) rest-exercise hemodynamic indices and to compare the association between indices of disease severity and hemodynamic abnormalities identified at rest versus exercise.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
6mo left

Started Feb 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Feb 2025Dec 2026

First Submitted

Initial submission to the registry

August 20, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 22, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

February 10, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

March 5, 2026

Status Verified

March 1, 2026

Enrollment Period

1.8 years

First QC Date

August 20, 2024

Last Update Submit

March 3, 2026

Conditions

Outcome Measures

Primary Outcomes (6)

  • Change in left ventricular end-systolic elastance from rest to peak exercise

    Change in left ventricular end-systolic elastance will be measured in ΔmmHg/mL

    Baseline

  • Change in Left ventricular cardiac output from rest to peak exercise

    Change in left ventricular cardiac output will be measured in ΔL/min

    Baseline

  • Change in systemic vascular resistance from rest to peak exercise

    Change in systemic vascular resistance will be measured in ΔWoods Units

    Baseline

  • Change in right ventricular free-wall strain from rest to peak exercise

    Change in right ventricular free-wall strain will be measured in Δ%

    Baseline

  • Change in right ventricular cardiac output from rest to peak exercise

    Change in right ventricular cardiac output will be measured in ΔL/min

    Baseline

  • Change in pulmonary vascular resistance from rest to peak exercise

    Change in pulmonary vascular resistance will be measured in ΔWoods Units

    Baseline

Study Arms (1)

Patients Undergoing Clinically indicated Cardiac Cath

EXPERIMENTAL
Procedure: Cardiac Cath

Interventions

Cardiac CathPROCEDURE

Patient will undergo standard of care Cardiac Cath and in addition invasive CPET (Cardiopulmonary exercise testing) will be performed during the procedure.

Patients Undergoing Clinically indicated Cardiac Cath

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Congenital Heart Disease Diagnosis
  • Undergoing Clinically indicated Cardiac Cath

You may not qualify if:

  • Unable to consent
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

RECRUITING

MeSH Terms

Conditions

Heart Defects, Congenital

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Alexander Egbe, M.B.B.S., M.P.H.

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

ACHD Research Program

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 20, 2024

First Posted

August 22, 2024

Study Start

February 10, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

March 5, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations